Acute Effects of Cannabigerol

Completed · Phase 1 · Has a placebo group

Conditions studied: Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition

In brief

The purpose of this study is to examine the effects of hemp-derived cannabigerol (CBG) on anxiety, stress, mood, and cognition. Further, the severity of various side effects of CBG (sleepiness, dry mouth, dry eyes, increased appetite) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.

Key facts

Study ID

NCT05257044

Run by

Washington State University

People needed

38

Starts

2022-03-24

Expected to finish

2023-11-28

Last updated by the study team

2026-06-02

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 21+ years of age
• reside in Washington state
• own a smartphone
• have access to a private environment where they can access a computer with a webcam connected to a high-quality and stable internet
• speak fluent English
• be literate
• have experience using cannabis-based products without serious adverse reactions

You may not qualify if…

• serious psychiatric disorders (e.g., psychotic disorder, bipolar disorder)
• neurological and other serious medical conditions including head injury
• pregnancy, or breastfeeding
• use of illicit substances in past 2 months

Where it is running

• Washington State University — Pullman, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.